Non-valvular AF is a common clinical condition associated with an increased risk of thromboembolic complications. As a consequence, ora anticoagulant therapy (OAT) is the cornerstone of non-valvular AF management. Despite the well-established efficacy of OAT, many patient cannot receive this preventive therapy due to bleeding or a high risk of bleeding. The fact that more than 90% of thrombi are formed in the lef atrial appendage has led to the development of alternative methods to reduce the embolic risk. Left atrial appendage occlusion (LAAO) is non-pharmacological option for preventing cardioembolic events in patients with non-valvular AF with a contraindication to OAT. The demand fo LAAO procedures is growing exponentially and clinicians should consider this alternative option when managing patients with a contraindicatio to OAT. This review summarises the current thinking about LAAO.

Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know / Merella, P.; Talanas, G.; Lorenzoni, G.; Denurra, C.; Atzori, E.; Casu, G.. - In: EUROPEAN CARDIOLOGY. - ISSN 1758-3756. - 18:(2023), p. e57. [10.15420/ecr.2023.18]

Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know

Casu G.
2023-01-01

Abstract

Non-valvular AF is a common clinical condition associated with an increased risk of thromboembolic complications. As a consequence, ora anticoagulant therapy (OAT) is the cornerstone of non-valvular AF management. Despite the well-established efficacy of OAT, many patient cannot receive this preventive therapy due to bleeding or a high risk of bleeding. The fact that more than 90% of thrombi are formed in the lef atrial appendage has led to the development of alternative methods to reduce the embolic risk. Left atrial appendage occlusion (LAAO) is non-pharmacological option for preventing cardioembolic events in patients with non-valvular AF with a contraindication to OAT. The demand fo LAAO procedures is growing exponentially and clinicians should consider this alternative option when managing patients with a contraindicatio to OAT. This review summarises the current thinking about LAAO.
2023
Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know / Merella, P.; Talanas, G.; Lorenzoni, G.; Denurra, C.; Atzori, E.; Casu, G.. - In: EUROPEAN CARDIOLOGY. - ISSN 1758-3756. - 18:(2023), p. e57. [10.15420/ecr.2023.18]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/323789
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact